who can use glp 1 for weight loss GLP-1 Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response The Science Behind GLP-1 Medications:

GLP1 RA Mechanisms of Action and Weight Loss As of January 2025, there are three incretin mimetic medications approved for treatment of overweight and obesity: liraglutide, semaglutide, and tirzepatide

The daily pill, called Foundayo, is the second oral GLP-1 to reach the market in recent months, following the approval of Novo Nordisks Wegovy pill in December

Here, we find support for this hypothesis, in that our participants taking GLP1-RAs had a delayed rise in BrAC up to 20 min post alcohol consumption

Haghighat N, Rajabi S, Mohammadshahi M

Bottom line: read the chart as the math of your dates and doses, never as a measured level in your blood